Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$505,360
-$44,175 QoQ
Shares Held
4,000
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,365
of 2,266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Architects, LLC holds $10,190,838 across 8 Drug Manufacturers - General names. GILD ranks #5 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,001 | $3,599,489 | |
| 2 | JNJ |
Johnson & Johnson
|
8,211 | $2,085,347 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,630 | $1,751,455 | |
| 4 | ABBV |
AbbVie Inc.
|
4,832 | $1,215,924 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
4,000 | $505,360 | |
| 6 | AMGN |
Amgen Inc
|
1,389 | $502,984 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,655 | $325,841 | |
| 8 | GSK |
GSK plc
|
3,900 | $204,438 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $505,360 | 4,000 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $549,535 | 3,943 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $751,046 | 6,119 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $678,765 | 6,115 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $681,185 | 6,144 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $694,822 | 6,201 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $568,999 | 6,160 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $533,054 | 6,358 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $437,663 | 6,379 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||